Contract with Customer, Liability, Current in USD of Can-Fite BioPharma Ltd. from Q4 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Current history and change rate from Q4 2022 to Q2 2025.
  • Can-Fite BioPharma Ltd. Contract with Customer, Liability, Current for the quarter ending 30 Jun 2025 was $405K, a 36.3% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $405K -$231K -36.3% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $405K -$217K -34.9% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $636K 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $622K -$161K -20.6% 31 Dec 2023 20-F 14 Apr 2025
Q4 2022 $783K 31 Dec 2022 20-F 28 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.